iBio, Inc.
IBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,720 | -$5,163 | -$4,861 | -$4,364 |
| Dep. & Amort. | $289 | $285 | $282 | $281 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $270 | $370 | $0 |
| Change in WC | -$529 | $8 | $1,118 | -$247 |
| Other Non-Cash | $295 | -$15 | -$14 | $461 |
| Operating Cash Flow | -$5,665 | -$4,615 | -$3,105 | -$3,869 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$32 | -$1 | -$14 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$21,461 | $46 | $0 | -$1 |
| Investing Cash Flow | -$21,493 | $45 | -$14 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$160 | -$183 | -$176 | -$170 |
| Stock Issued | $46,760 | $2,410 | $1,127 | $18 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $105 | $5,953 | $112 | $0 |
| Financing Cash Flow | $46,705 | $8,180 | $1,063 | -$152 |
| Forex Effect | -$18 | $0 | $0 | $0 |
| Net Chg. in Cash | $19,529 | $3,610 | -$2,056 | -$4,023 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,582 | $5,182 | $7,238 | $11,038 |
| End Cash | $28,111 | $8,792 | $5,182 | $7,015 |
| Free Cash Flow | -$5,697 | -$4,616 | -$3,119 | -$3,870 |